Blackstone Group secures USD 3.4 billion life sciences fund Farhat Nasim10 Jan 2020 9:15 AM ISTSince it set up a life sciences unit, Blackstone has unveiled a joint venture with Novartis AG to develop a novel heart treatment and invested $400...
Blueprint gets USFDA nod for cancer therapy Ayvakit Farhat Nasim10 Jan 2020 9:00 AM ISTThe USFDA's decision makes Blueprint Medicines' cancer therapy, Ayvakit, the first treatment for a small subset of patients with a mutation of cancer...
Abbott gets USFDA nod for less-invasive surgical approach for heart pump Medical Dialogues Bureau9 Jan 2020 3:32 PM ISTNew Delhi: Abbott recently announced U.S. Food and Drug Administration (USFDA) approval of a new alternative surgical technique for Abbott's HeartMate...
Aleor Derma Karakhadi unit clears USFDA inspection Medical Dialogues Bureau9 Jan 2020 1:33 PM ISTMumbai: Drugmaker Alembic Pharma recently informed the bourses that its Joint Venture, Aleor Dermaceutical has successfully completed the US drug...
Strides Pharma appoints former Cipla Chief Operating Officer Dr R Ananthanarayanan as new CEO, MD Medical Dialogues Bureau9 Jan 2020 9:30 AM ISTUntil joining Strides Pharma, Dr R Ananthanarayanan was the Global Chief Operating Officer at Cipla Limited.Bangalore: Strides Pharma Science Limited...
Novartis acquires The Medicines Company, adds cholesterol-lowering therapy inclisiran Medical Dialogues Bureau9 Jan 2020 9:22 AM ISTNew Delhi: Novartis AG (Novartis) recently announced that it has completed the acquisition of The Medicines Company (the “Company”) through the...
Esteve to buy German pharma firm Riemser from Ardian Medical Dialogues Bureau9 Jan 2020 9:00 AM ISTRiemser specialises in oncology, neurology, and infectiology and had since 2012 been part of Ardian's portfolio. Ardian in 2018 unsuccessfully tried...
Daiichi Sankyo introduces Enhertu - breast cancer drug in US Medical Dialogues Bureau8 Jan 2020 2:08 PM ISTTokyo and Basking Ridge, NJ – Daiichi Sankyo announced that ENHERTU® (fam-trastuzumab deruxtecan-nxki), a HER2 directed antibody-drug conjugate, is...
Antiepileptic drug Lamotrigine will have to carry warning for hemophagocytic lymphohistiocytosis: CDSCO Medical Dialogues Bureau8 Jan 2020 11:42 AM ISTNew Delhi: Commonly used bipolar disorder and epilepsy bipolar drug Lamotrigine will have to now carry mandatory safety alert in its leaflet regarding...
Slayback Pharma raises USD 50 million in Series B funding from Everstone Group Medical Dialogues Bureau7 Jan 2020 3:26 PM ISTIn addition to the investment, Everstone Managing Directors Arjun Oberoi and Puncham Mukim will join Slayback Pharma's Board of Directors. Everstone...
DCGI to conduct Special Public Hearing every month; Details Farhat Nasim7 Jan 2020 2:15 PM ISTAs per the order, a special hearing will be conducted at the DCGI Office every month. Every second and the fourth Wednesday, from 3 in the evening has...
Glenmark gets USFDA nod for Deferasirox tablets to treat high levels of iron Farhat Nasim7 Jan 2020 11:55 AM IST"Glenmark Pharmaceuticals Inc, USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (US FDA) for...
